ATC code V03

ATC codes

V Various

V01 Allergens

V03 All other therapeutic products

V04 Diagnostic agents

V06 General nutrients

V07 All other non-therapeutic products

V08 Contrast media

V09 Diagnostic radiopharmaceuticals

V10 Therapeutic radiopharmaceuticals

V20 Surgical dressings

ATC code V03 All other therapeutic products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup V03 is part of the anatomical group V Various.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QV03...^[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

V03A All other therapeutic products

V03AB Antidotes

V03AB01 Ipecacuanha

V03AB02 Nalorphine

V03AB03 Edetates

V03AB04 Pralidoxime

V03AB05 Prednisolone and promethazine

V03AB06 Thiosulfate

V03AB08 Sodium nitrite

V03AB09 Dimercaprol

V03AB13 Obidoxime

V03AB14 Protamine

V03AB15 Naloxone

V03AB16 Ethanol

V03AB17 Methylthioninium chloride

V03AB18 Potassium permanganate

V03AB19 Physostigmine

V03AB20 Copper sulfate

V03AB21 Potassium iodide

V03AB22 Amyl nitrite

V03AB23 Acetylcysteine

V03AB24 Digitalis antitoxin

V03AB25 Flumazenil

V03AB26 Methionine

V03AB27 4-dimethylaminophenol

V03AB29 Cholinesterase

V03AB31 Prussian blue

V03AB32 Glutathione

V03AB33 Hydroxocobalamin

V03AB34 Fomepizole

V03AB35 Sugammadex

V03AB36 Phentolamine

V03AB37 Idarucizumab

QV03AB90 Atipamezole

QV03AB91 Sarmazenil

QV03AB92 Diprenorfin

QV03AB93 Yohimbine

QV03AB94 Tolazoline

V03AC Iron chelating agents

V03AC01 Deferoxamine

V03AC02 Deferiprone

V03AC03 Deferasirox

V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia

V03AE01 Polystyrene sulfonate

V03AE02 Sevelamer

V03AE03 Lanthanum carbonate

V03AE04 Calcium acetate and magnesium carbonate

V03AE05 Sucroferric oxyhydroxide

V03AE06 Colestilan

V03AE07 Calcium acetate

V03AE08 Ferric citrate

V03AF Detoxifying agents for antineoplastic treatment

V03AF01 Mesna

V03AF02 Dexrazoxane

V03AF03 Calcium folinate

V03AF04 Calcium levofolinate

V03AF05 Amifostine

V03AF06 Sodium folinate

V03AF07 Rasburicase

V03AF08 Palifermin

V03AF09 Glucarpidase

V03AF10 Sodium levofolinate

V03AG Drugs for treatment of hypercalcemia

V03AG01 Sodium cellulose phosphate

V03AH Drugs for treatment of hypoglycaemia

V03AH01 Diazoxide

V03AN Medical gases

V03AN01 Oxygen

V03AN02 Carbon dioxide

V03AN03 Helium

V03AN04 Nitrogen

V03AN05 Medical air

V03AX Other therapeutic products

V03AX02 Nalfurafine

V03AX03 Cobicistat

V03AZ Nerve depressants

V03AZ01 Ethanol

References

↑ "ATC/DDD Index 2016: code V03". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2016: code QV03". WHO Collaborating Centre for Drug Statistics Methodology.

Antidotes (V03AB)

Nervous
system

Nerve agent / Organophosphate poisoning	Atropine^# Biperiden Diazepam^# Oximes Obidoxime Pralidoxime see also: Cholinesterase

Barbiturate overdose	Bemegride Ethamivan

Benzodiazepine overdose	Cyprodenate Flumazenil

GHB overdose	Physostigmine SCH-50911

Opioid overdose	Diprenorphine Doxapram Nalmefene Nalorphine Naloxone^# Naltrexone

Reversal of neuromuscular blockade	Sugammadex

Circulatory
system

Beta blocker	Glucagon

Digoxin toxicity	Digoxin Immune Fab

Heparin	Protamine^#

Other

Arsenic poisoning	Dimercaprol^# Succimer

Cyanide poisoning	4-Dimethylaminophenol Hydroxocobalamin nitrite Amyl nitrite Sodium nitrite^# Sodium thiosulfate^#

Hydrofluoric acid	Calcium gluconate^#

Methanol / Ethylene glycol poisoning	Primary alcohols: Ethanol Fomepizole

Paracetamol toxicity (Acetaminophen)	Acetylcysteine^# Glutathione Methionine^#

Toxic metals (cadmium lead mercury thallium)	Dimercaprol^# Edetates Prussian blue^#

Other	iodine-131 Potassium iodide Methylthioninium chloride^# oxidizing agent Potassium permanganate Prednisolone/promethazine

Emetic

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Chelating agents / chelation therapy (V03AC, others)

Copper	Penicillamine^#

Iron	Deferasirox Deferiprone Deferoxamine^#

Lead	BAL^# EDTA^# Dexrazoxane

Thallium	Prussian blue

Other	ALA BAPTA DMPS DMSA DTPA EGTA

^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

Drugs for treatment of hyperkalemia and hyperphosphatemia (V03AE)

Potassium binders	Patiromer Polystyrene sulfonate

Phosphate binders	Aluminium hydroxide Calcium acetate Calcium acetate/magnesium carbonate Calcium carbonate Colestilan Lanthanum carbonate Sevelamer Sucroferric oxyhydroxide

Detoxifying agents for chemotherapy treatment (V03AF)

Folic acid / methotrexate	Salts of Folinic acid calcium folinate/calcium levofolinate sodium folinate/sodium levofolinate

Uric acid (TLS)	Rasburicase

Acrolein / nitrogen mustards	Mesna

Iron / anthracyclines	Dexrazoxane

Alkylating agents	Amifostine

Keratinocyte growth factor	Palifermin

Other therapeutic products (V03AG–V03AZ)

Treatment of hypercalcemia	Sodium cellulose phosphate

Treatment of hypoglycaemia	Diazoxide

Medical gases	Oxygen Carbon dioxide Helium Nitrogen

Nerve depressants	Ethanol

This article is issued from Wikipedia - version of the Monday, January 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.